NEWS
An Analysis of the “Long-lasting Efficacy” of the MiStent Stent
March 14, 2025
The MiStent coronary drug-eluting stent, an important overseas transformation project of Kossel Medtech has officially entered the Chinese market with two major advantages of “rapid
Mistent® Fast Healing” in Stent Analysis
March 6, 2025
Mistent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech, has officially launched in the Chinese market with two advantages of
Good News 丨 Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Non – compliant Balloon Dilatation Catheter Approved in India, Accelerating Expansion in the Asian Market!
January 21, 2025
At the beginning of 2025, good news keeps coming. The two products, Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Balloon Dilatation Catheter independently
Strong Debut of MiStent® Coronary Drug-eluting Stent System
October 31, 2024
MiStent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech (Suzhou) Co., Ltd., has officially landed in the Chinese market with two advantages